SCAI

This channel contains news about the Society for Cardiac Angiography and Interventions (SCAI), including coverage of its annual meeting and links to recently released practice guidelines. SCAI is a leading resource in interventional cardiology and cath lab techniques and technologies.

SCAI Updates Expert Consensus Statement on Best Practices for Transradial Access

January 15, 2020 — The Society for Cardiovascular Angiography and Interventions (SCAI) released an updated expert consensus statement for the...
EXCEL Trial Authors Say European Surgery Society Claims of Bad Science Are Groundless

January 2, 2020 — In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for...
VIDEO: SCAI Prospective on Key Takeaways at TCT 2019

Chandan Devireddy, M.D., offers insights about what he saw as the top take aways from...
Study Shows Inducing a Heart Attack Helps Valve Patients

A study of a procedure developed at Henry Ford Health System shows inducing a heart attack in patients with heart disease could be a viable option for patients in need of mitral valve replacement...

The Society for Cardiovascular Angiography and Interventions (SCAI) released an updated expert consensus statement for the “SCAI Best Practices for Transradial Angiography and Intervention.”

News | Radial Access | January 15, 2020

SCAI Updates Expert Consensus Statement on Best Practices for Transradial Access

January 15, 2020 — The Society for Cardiovascular Angiography and...

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes. In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.

News | Cath Lab | January 02, 2020 | Dave Fornell, Editor

EXCEL Trial Authors Say European Surgery Society Claims of Bad Science Are Groundless

January 2, 2020 — In early December 2019, leaders of the European...

Videos | TCT | October 04, 2019

VIDEO: SCAI Prospective on Key Takeaways at TCT 2019

Chandan...

Study Shows Inducing a Heart Attack Helps Valve Patients. This image shows a left-ventricular outflow tract (LVOT) obstructed by an Edwards Sapien TAVR valve used for a valve-in-valve procedure. The arrow points to the small, crescent shaped dark area of the neo-LVOT, which did not allow enough blood to flow from the left ventricle into the aorta and the rest of the body. To prevent this issue, the procedure used by Henry Ford ablates some of the tissue in the septum to allow for a larger LVOT area.

This image shows a left-ventricular outflow tract (LVOT) obstructed by an Edwards Sapien TAVR valve used for a valve-in-valve procedure. The arrow points to the small, crescent shaped dark area of the neo-LVOT, which did not allow enough blood to flow from the left ventricle into the aorta and the rest of the body. To prevent this issue, the procedure used by Henry Ford ablates (kills) some of the tissue in the cardiac septum to allow these valves to fit better and allow for an enlarged neo-LVOT for patients who otherwise could not receive this therapy.

News | Heart Valve Technology | July 03, 2019

Study Shows Inducing a Heart Attack Helps Valve Patients

July 3, 2019 — A ...